Calibrant Announces Brain Cancer Drug Discovery Program with Cleveland Clinic

January 25, 2008 08:02 AM Eastern Time


GAITHERSBURG, Md.--(BUSINESS WIRE)--Calibrant Biosystems today announced a research collaboration with the Cleveland Clinic to identify novel drug targets for primary brain cancer using Calibrant’s Gemini proteomics platform. As part of the partnership, Calibrant will identify protein networks and novel therapeutic targets involved in the progression of the most common and aggressive primary brain cancer, glioblastoma multiforme (GBM).

“Our collaboration represents another important cancer drug program for Calibrant,” stated Dr. Brian Balgley, Chief Technology Officer of Calibrant Biosystems. “The study reflects Calibrant’s ability to apply the Gemini platform to targeted discovery from microdissected cell populations for the effective identification of disease-relevant pathways and drug targets.” Calibrant’s collaborator, Robert J. Weil, M.D., is the Melvin Burkhardt Chair of Brain Tumor Research and Director of Laboratory Research in the Brain Tumor & Neuro-Oncology Center at Cleveland Clinic.

This latest partnership with the Cleveland Clinic adds tremendous value to Calibrant’s existing drug discovery collaborations. Calibrant has recently established several drug discovery collaborations with world-renowned medical research centers this year, leading to active therapeutic programs for cancer indications including breast and ovarian cancer.

About Calibrant Biosystems

Calibrant Biosystems is a Gaithersburg, MD biotechnology company specializing in targeted drug discovery from clinical tissue specimens. Calibrant’s advanced Gemini discovery platform, which is compatible with both fresh and formalin-fixed archival tissues, provides the unique ability to comparatively map protein networks between different cell types within a single tissue section. With an initial focus on monoclonal antibody drug development in oncology, Calibrant is leveraging the Gemini platform for the development of first-in-class therapeutics across a range of cancer indications. More information is available at www.calibrant.com.

Note: Gemini is a trademark of Calibrant Biosystems.

Contacts

Calibrant Biosystems
Dr. Michael Salgaller
Chief Operating Officer
301-977-7900
michael.salgaller@calibrant.com

0 comments:

Buzz Apparel - Support Brain Tumor Research

Fox Valley Brain Tumor Coalition - Journey of Hope Walk

The Journey of Hope is our major fundraiser of the year, allowing us to raise most of the funds that we need to survive. This event is critical to the success of this group, so we hope you can join us!

With over 750 walkers, the Fox Valley Brain Tumor Coalition puts on a great party the Saturday after Labor Day every year. The non-competitive walk is held on the grounds of NeuroSpine Center of Wisconsin. Our paved ½ mile trail is short enough for nearly everyone to make at least one lap around, and is accessible to wheelchairs! For those who like more of a challenge, we encourage as many laps as you are able to do!

The day is a celebration of those fighting brain tumors and remembering those who have lost their battle. The walk starts with a ceremony at the Tree of Hope, with testimonials from those most affected by this disease, as well as a dedication from neurosurgeon Thomas Wascher MD, one of our biggest supporters.

Once you have built up your appetite from the walk, come in to our party tent for a great home-cooked picnic. We have fresh roasted corn-on-the-cob, hamburgers, hot dogs, chips and sweets! Vegetarian selections are available for those with restricted diets.

A huge silent auction, kids games, music, pictures and more makes this party fun for everyone!

As always, dogs are welcome, but should always be on a leash…we will provide water for our four legged friends!

Your registration cost of $10 (yes still only $10 after all these years!!!) includes a great t-shirt with all of our corporate sponsors proudly displayed, lunch and all the fun you can handle!

New this year is our online registration and personal web page, making it easier for your family and friends to support your efforts.

My Team